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ABSTRACT 
 
Impact of Ghrelin and Cocaine on Intracranial Self-Stimulation in Rats. (April 2010) 
 
Tracey Christine Kniffin 
Department of Psychology 
Texas A&M University 
 
Research Advisor: Dr. Paul Wellman 
Department of Psychology 
 
Ghrelin (GHR) is a 28-amino acid peptide that is secreted in the peripheral and central 
nervous systems and correlates with hunger. GHR is the only gut hormone known to 
stimulate food intake. Psychostimulant drugs, such as cocaine (COC), induce locomotion 
and augment reward-seeking behavior. Recent studies have examined the effects of 
GHR on locomotion and report an augmenting effect when combined with COC. In the 
present study, we examine the effects of systemic injections of COC, GHR, and a pairing 
of both on rate-frequency curves, maximal response rate, and threshold (the frequency 
that produces 50% of the maximal response rate) obtained during intracranial self-
stimulation (ICSS) of the medial forebrain bundle (MFB). In this task, rats press a lever 
to deliver electrical pulses to their own brain via an implanted electrode. Rats are run in 
75 minute sessions, consisting of five 15-minute passes; during each pass, the intensity 
(in μamps) is kept constant, while the frequency of stimulation is lowered each minute 
from 141 Hz to 28 Hz (decreased in 0.05 log units). Each rat runs multiple trials on 
separate days and is injected with either vehicle (0.5 ml saline), COC (0, 2.5, and 5.0 
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mg/kg), GHR (5.0, 10.0, and 30.0 nMol/rat), or a combination of GHR and COC (10.0 
nMol/rat GHR and 2.5 mg/kg COC). GHR produced a significant dose-dependent effect, 
where the rate-frequency curves shifted to the right, maximal response rate and 50% 
response rate decreased, and threshold increased.  COC produced the opposite effect.  A 
combination of GHR and COC shifted the rate-frequency curves to the right and caused 
a significant increase in threshold.  Dopamine (DA) plays a critical role in reinforcement 
and is found in neurological reward pathways, such as the ventral tegmental area (VTA) 
and the nucleus accumbens (NA). Since GHR receptors exist in these two areas, some 
researchers suggest that there may be a common pathway shared by the rewarding 
aspects of food and psychostimulants leading to obesity and drug abuse, respectively.  
The present results suggest that in some circumstances, GHR may inhibit already active 
reinforcement systems. 
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Food restriction (FR) has been commonly used to facilitate the acquisition of cocaine 
(COC) or amphetamine self-administration (SA) and to increase the acquisition of COC-
induced conditioned place preference (Wellman et al., 2005).  Due to the effects of FR 
on drug-seeking behavior, it has commonly been used as a technique to facilitate shaping 
rats to SA psychostimulants (Bell et al., 1997; Carroll, 1985).  Ghrelin (GHR) is a 28-
amino acid peptide that is secreted in the peripheral and central nervous systems which 
has been observed to correlate with hunger, and it is possible that FR acts by increasing 
GHR levels in the body (Gardiner et al., 2008). 
 
Several observations support the idea that GHR is directly related to FR such as the fact 
that GHR levels rise prior to and fall after meals.  Additionally, GHR is the “only known 
gut hormone to stimulate food intake” (Gardiner et al., 2008).  It should be noted that 
increased GHR is not the only effect of FR and represents only one of the possible 
pathways affected by a decrease in energy intake or availability.  Therefore, the effects 




This thesis follows the style of Pharmacology, Biochemistry and Behavior. 
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Previous studies have shown that GHR does not only act to mimic the effects of FR and 
cause an increase in dietary consumption.  GHR was also found to operate on the reward 
center of the brain that “communicates the hedonic and reinforcing aspects of natural 
rewards, e.g. food, as well as of addictive drugs” (Jerlhag et al., 2008).  This may 
represent a common pathway in the brain shared by feeding and addiction.  In other 
words, the feeding-relevant neural systems affected by FR may also “modulate the 
neural substrates by which cocaine and other psychostimulants alter locomotion and 
reinforcement” (Wellman et al., 2005).   
 
It has been noted in recent research that “ghrelin may influence the activity of wide 
brainstem-hypothalamic pathways and networks” and its presence in reward regions 
such as the ventral tegmental area (VTA) suggests a link between GHR and feeding for 
reasons other than hunger or pure energy consumption (e.g. GHR may have a 
pharmacological effect independent of energy state).  Specifically, GHR has been linked 
to the reward aspect of hunger, termed palatability (Olszewski et al., 2008).  This 
suggests that GHR may influence the effects of COC when the two substances are 
presented together by acting on the reward center of the brain.  Additionally, GHR has 
been found to increase the extracellular dopamine (DA) levels in the nucleus accumbens 
(NA) and also to augment COC-induced locomotion (Jerlhag et al., 2008; Quarta et al., 
2009; Wellman et al., 2005).  In a test of conditioned reward, Davis et al. (2007) 
reported that GHR facilitated the conditioned reinforcing effects of low COC doses 
(0.312 or 0.625 mg/kg) but repressed the reinforcing effect of a higher COC dose (1.25 
  3 
mg/kg).  Therefore, in some instances it appears that GHR administration can facilitate 
brain reinforcement associated with COC, but in other instances can inhibit it.  There are 
currently no studies that report of the effects of GHR administration on the intravenous 
SA of COC. 
 
An alternative to the SA method is intracranial self-stimulation (ICSS), a procedure in 
which a rat is surgically implanted with an electrode in the medial forebrain bundle 
(MFB).  The MFB is part of the mesolimbic pathway (with projections from the VTA to 
the NA), a well-known reinforcement system in the brain, and electrical stimulation of 
this area has been found to be reinforcing (Wise & Rompre, 1989).  In this method, the 
rat is allowed to press a lever to stimulate its own brain; presumably this stimulation is 
pleasurable.  Moreover, a change in the amount of effort a rat is willing to exert to obtain 
this stimulation is related to the degree of pleasure gained by the stimulation. Reductions 
in brain reward result in less effort while increases in brain reward result in greater 
effort.  To date no published study has examined the impact of GHR on brain 
stimulation reward nor examined the interaction of COC and GHR on ICSS.  
 
By researching the effect of COC, GHR, and a combination of both on ICSS, we will be 
able to better understand the processes that modify the reinforcing effects of COC and 
other psychostimulants.  The gut peptide effects of GHR on COC make it one of only a 
few factors known to change the locomotion effects and reinforcing actions of COC.  
Other factors that modify the effects of COC are FR, stress, and ovarian hormones 
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(Wellman et al., 2005).  With further research in this area, it may be possible to 
determine how to inhibit or augment the reinforcing effects of COC.  Specifically, by 
examining the effects of COC and GHR on the threshold current required to support 
ICSS, we can better understand the effects GHR has on reward (Wellman et al., 2008). 
 
The current study examined the effects of GHR, COC, and a combination of both on 
rodent ICSS and reward-seeking behavior.  COC is known to increase ICSS at an 
injection of 1.25 mg/kg and to so profoundly increase ICSS responding with an injection 
of 5.0 mg/kg that animals continue lever-pressing until the end of trials without reaching 
a breakpoint (Wellman et al., 2008).  The effects of GHR alone and GHR combined with 
COC on ICSS are unknown.  The following hypotheses were the expected results of this 
research. 
 
Hypothesis 1: An injection of systemic GHR will decrease rodent ICSS, indicating a 
decrease in reward-seeking behavior; however because the existing literature on GHR 
and reinforcement is conflicting, it is possible that GHR will facilitate rodent ICSS. 
 
Hypothesis 2: An injection of COC will increase rodent ICSS, indicating an increase in 
reward-seeking behavior. 
 
Hypothesis 3: An injection of systemic GHR followed by an injection of COC will 
decrease rodent ICSS or produce a smaller increase in ICSS than that produced by COC 
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administration alone.  Alternatively, if GHR alone augments ICSS, then the combination 
may result in more activation than that induced by COC alone. 
 





The animals used were 9 adult male Sprague-Dawley albino rats (Harlan Industries, 
Houston, TX) weighing between 300-450 grams at the beginning of the study.  The 
animals were housed individually in standard plastic rodent cages in a holding room and 
were allowed a 1-week adaptation period prior to the onset of behavioral testing in order 
to acclimatize them to daily handling and colony maintenance procedures.  The animal 
holding room was maintained at 23+1.0°C, with a 12:12 L:D lighting schedule (lights 
off at 10:00 h).  The rats were provided with continuous access to tap water and rodent 
chow pellets (Teklad).  The procedures of the study were approved by the Texas A&M 
University Institutional Animal Care and Use Committee. 
 
Drugs 
COC solutions were prepared by dissolving COC hydrochloride (a gift provided by Dr. 
Kevin Gromley of the Basic Research Division of NIDA) into 0.9% saline at 
concentrations of 2.5 and 5.0 mg/ml.  COC solutions were calculated as the salt.  GHR 
solutions were prepared by dissolving rat GHR (No. B2709002; Piproteomics, 
Huntsville, AL) into a vehicle of 0.5 ml saline at concentrations of 5.0, 10.0, and 30.0 
nMol.   
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Surgical procedures 
Prior to surgery, each rat was injected (i.p.) with 0.4 mg/kg atropine sulfate (to minimize 
bronchial secretions), and then anesthetized with an injection (i.p.) of ketamine (Ketaset: 
60 mg/kg) and xylazine (20 mg/kg).  Each rat was mounted in a stereotaxic frame and 
the scalp incised using a sterile technique.  A 2% lidocaine jelly was applied to the 
incised edges of the scalp.  The periosteum was mechanically retracted and skull 
bleeding was terminated using a styptic gel (Kwik-Stop; Gimborn Pet, Atlanta, GA).  A 
bipolar stimulating electrode with 0.125-mm wire diameter (No. 303/3; Plastics One, 
Roanoke, VA) was implanted into the MFB at the level of the lateral hypothalamus.  The 
incisor bar was set at -2.7 mm, and coordinates were 3.2 mm posterior to bregma, 1.7 
mm lateral to the sagittal suture, and 8.3 mm ventral to the skull surface.  Electrodes 
were affixed to the skull with four skull screws and dental acrylic (Lang Dental; 
Wheeling, IL).  The lateral edges of the scalp incision were coated with a 0.1% 
gentamicin sulfate ointment (E. Fougera; Melville, NY) and the ends of the incision 
were closed using cyanoacrylate.  Following surgery, each rat was injected (i.m.) with 
penicillin (300,000 units each).  A 7-day recovery period followed surgery, during which 




The test chamber (Cambden Instruments) was constructed of Plexiglass and stainless 
steel with dimensions of 28x22x22 cm (Fig. 1).  Two levers were mounted on opposite 
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sides of one wall 7 mm above the floor.  Depression of the right lever was without 





Fig. 1. Testing Apparatus.  Lateral view of the ICSS test chamber.  The lever on 











  9 
train of monophasic rectangular pulses with 1-ms pulse duration delivered from a Grass 
S88 stimulator (Grass Instruments, Quincy, MA) and a constant current simulator 
(Model DS3; Digitimer, Hertfordshire, England) to the brain via a commutator and a 
flexible cable (Plastics One).  All stimulation parameters were monitored on an 
oscilloscope (Model 645280; Jameco Electronics, Belmont, CA). 
 
Procedure 
After the recovery period, each rat was shaped to lever-press for rewarding brain 
stimulation on a fixed ratio-1 schedule.  During shaping, current intensity was 
systematically increased until a minimum rewarding current (a current sufficient to elicit 
lever responding) was reached (typically between 50-200 μamps).  Once the lever-
pressing behavior was acquired, animals were run through 75 minute baseline trials 
consisting of five separate 15-minute passes.  During each 15-minute pass the intensity 
was kept constant while the frequency of stimulation was lowered each minute from 141 
Hz to 28 Hz (decreased in 0.05 log units).  During testing, each rat ran multiple trials on 
separate days and was injected (i.p.) with either vehicle (0.5 ml saline), COC (0, 2.5, and 
5.0 mg/kg), GHR (5.0, 10.0, and 30.0 nMol/rat), or a combination of GHR and COC 
(10.0 nMol/rat GHR and 2.5 mg/kg COC).  GHR was injected one hour before the 
beginning of each trial and vehicle and COC were both injected 30 minutes before the 
beginning of each trial.  Two days of vehicle trials were interposed between each drug 
trial.  The number of lever-presses per minute was recorded for each rat throughout each 
75 minute trial.  
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Histological analyses 
At the conclusion of the experiment, each rat was overdosed with sodium pentobarbital 
(100 mg/kg, i.p.), and perfused through the heart with 0.9% formalin.  Further fixation in 
10% formalin/30% sucrose proceeded for at least 72 hours prior to sectioning each brain.  
Alternate 80 micron frozen sections were stained with cresyl violet and cover-slipped for 
permanent storage.  Coronal scans were compared to standard atlas plates to verify 
electrode placements (Paxinos & Watson, 2005). 
 
Data analyses 
For each rat and session, the total number of responses, rate-frequency curve, maximal 
response rate (100% response rate), 50% response rate, and threshold (frequency which 
produced 50% response rate) were calculated for post-injection tests and compared to 
values obtained during baseline trials.  Maximal response rate, 50% response rate, and 
threshold were assessed using one-way repeated measures analyses of variance and 
Holm-Sidak contrast tests.  Differences less than 0.05 were deemed statistically 
significant. 





After testing, electrode placements were verified via histological analysis and all animals 
used in the present study showed correct electrode placement within the MFB at the 





Fig. 2. Histological Analysis. A representative sample of electrode placement 
within the MFB at the level of the lateral hypothalamus.  Fig. is derived from The 
Rat Brain (Paxinos & Watson, 2005). 
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GHR group analysis 
Figure 3 depicts the rate-frequency curves for GHR trials with 0, 5.0, 10.0, and 30.0 
nMol/rat GHR.  After systemic injections of GHR, the rate-frequency curves dose-




































Fig. 3. Rate-frequency Curve for GHR Trials.  Mean group response rates as a 
function of stimulation frequency for rats. Rats treated one hour prior to each test 
session with either 0.5 ml saline (VEH), 5.0, 10.0 or 30.0 nMol/rat GHR. Group 
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increased.  Figure 4A-C depicts the mean group changes in ICSS responding after GHR 
administration.  Panel A depicts the mean maximal response rate, panel B depicts the mean 50% 
response rate, and panel C depicts the mean threshold (frequency necessary to produce the 50% 
response rate) for the GHR testing condition.  A one-way analysis of variance test, 
computed using Sigma Stat 3.0 (Systat Corporation; San Jose, CA), confirmed these 
results were significant between groups for the maximal response rate (100% response 
rate) (F(3,12) = 10.371, p<0.001).  Additional analysis with the Holm-Sidak method 
compared the GHR dose values to the control condition and indicated a significant 
reduction in 100% response rate between each GHR dose (5.0, 10.0, and 30.0 nMol/rat 
GHR) and the control dose (0.5 ml saline) (p<at least 0.05).  Similarly, a one-way 
analysis of variance test of the 50% response rate values showed that the results were 
significant between groups in GHR treatment (F(3,12) = 12.455, p<0.001).  Analysis 
with the Holm-Sidak method also indicated a significant difference in 50% responses 
between each GHR dose and the control dose (p<at least 0.05).  Finally, analysis of the 
threshold using a one-way analysis of variance test confirmed that the results were 
significant between groups (F(3,12) = 10.999, p<0.001).  However, analysis with the 
Holm-Sidak method indicated a significant difference between the 10.0 and 30.0 
nMol/rat GHR doses and the control dose (0.05 ml saline), but did not indicate a 
significant difference between the 5.0 nMol/rat GHR dose and the control dose (p<at 
least 0.05). 





















































































Fig. 4.  Mean Group Changes in ICSS Responses after 0, 5.0, 10.0, or 30.0 
nMol/rat GHR. Panel A: Maximal response rate for ICSS; Panel B: 50% 
response rate for ICSS; Panel C: Threshold for ICSS. 
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COC group analysis 
Figure 5 depicts the rate-frequency curves for COC trials with 0, 2.5, and 5.0 mg/kg 
COC.  After systemic injections of COC, the rate-frequency curves dose-dependently 

































Fig. 5. Rate-frequency Curve for COC Trials.  Mean group response rates as a 
function of stimulation frequency for rats. Rats treated 30 min prior to each test 
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Figure 6A-C depicts the mean group changes in ICSS responding after COC administration.  
Panel A depicts the mean maximal response rate, panel B depicts the mean 50% response rate, 
and panel C depicts the mean threshold for the COC testing condition.  A one-way analysis of 
variance test confirmed these results were significant between groups for the maximal 
response rate (100% response rate) (F(2,4) = 7.009, p<0.049).  Additional analysis with 
the Holm-Sidak method compared each COC dose value to the control condition and 
indicated a significant difference between the 5.0 mg/kg dose of COC and the control 
dose (0.5 ml saline), but no significant difference between the 2.5 mg/kg dose of COC 
and the control dose (p<at least 0.05).  One-way analysis of variance test of the 50% 
response rate did not show a significant difference between groups in COC treatment 
with 0, 2.5, and 5.0 mg/kg doses (F(2,4) = 3.295, p<0.143).  Finally, analysis of the 
threshold using a one-way analysis of variance test did not show a significant difference 





























































































Fig. 6.  Mean Group Changes in ICSS Responses after 0, 2.5, or 5.0 mg/kg COC. 
Panel A: Maximal response rate for ICSS; Panel B: 50% response rate for ICSS; 
Panel C: Threshold for ICSS. 
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Combination group analysis 
Figure 7 depicts the rate-frequency curves for the combination GHR and COC trials with 
vehicle (0.5 ml saline), 10.0 nMol/rat GHR, and 2.5 mg/kg COC combined with 10.0 
































10.0 GHR & 2.5 COC
 
Fig. 7. Rate-frequency Curve for Combination Trials.  Mean group response 
rates as a function of stimulation frequency for rats. Rats treated one hour prior 
to each test session with 10.0 nMol/rat GHR and 30 min prior to each test 
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frequency curves shifted to the right and the maximal response rate decreased.  Figure 8 
A-C depicts the mean group changes in ICSS responding after administration of GHR and 
COC.  Panel A depicts the mean maximal response rate, panel B depicts the mean 50% response 
rate, and panel C depicts the mean threshold for the combination testing condition.  A one-way 
analysis of variance test confirmed these results were significant between groups for the 
threshold (F(2,4) = 8.710, p<0.035).  Additional analysis with the Holm-Sidak method 
compared each dose value to the control condition and indicated a significant difference 
between the combination dose (2.5 mg/kg COC and 10.0 nMol/rat GHR) and the control 
dose (0.5 ml saline), but no significant difference between the 10.0 nMol/rat GHR dose 
and the control dose (p<at least 0.05).  One-way analysis of variance test of the maximal 
response rate (100% response rate) did not show a significant difference between groups 
(F(2,4) = 1.197, p<0.391).  Finally, analysis of the 50% response rate did not show a 






























































































Fig. 8.  Mean Group Changes in ICSS Responses after 0, 10.0 nMol/rat GHR, or 
10.0 nMol/rat GHR and 2.5 mg/kg COC.  Panel A: Maximal response rate for 
ICSS; Panel B: 50% response rate for ICSS; Panel C: Threshold for ICSS. 
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Across trials analysis 
Figure 9 depicts the rate-frequency curves for the animal that was run in every trial of 
the current experiment (GHR, COC, and combination trials).   After systemic injections 
of 10.0 nMol/rat GHR, the rate-frequency curves shifted to the right and the maximal 
response rates decreased.  After systemic injections of the 2.5 mg/kg COC, the rate-
frequency curves shifted to the left and the maximal response rates increased.  After 
systemic injections of a combination of 2.5 mg/kg COC and 10.0 nMol/rat GHR, the 
rate-frequency curves shifted to the right and the maximal response rate decreased (both 
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Log Stimulation Frequency



























10.0 GHR & 2.5 COC 
 
Fig. 9. Rate-frequency Curve for Animal Run on All Test Conditions.  Mean 
response rates as a function of stimulation frequency for one rat. Rat was treated 
one hour prior to each test session with 10.0 nMol/rat GHR during GHR trials, 30 
min prior to each test session with 2.5 mg/kg COC during COC trials, and one 
hour prior with 10.0 nMol/rat GHR and 30 min prior with 2.5 mg/kg COC prior 
to each test session during combination trials.  Group size are n=1. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
Summary  
The major findings of the present experiment are that systemic administration of 5.0, 
10.0, and 30.0 nMol/rat GHR causes a significant, dose-dependent reduction in maximal 
response rate and 50% response rate, and an increase in threshold for ICSS.  In contrast, 
administration of 2.5 and 5.0 mg/kg COC caused a significant increase in maximal 
response rate, and the trend in COC data for 50% response rate and threshold mimicked 
that of other experiments (increase in 50% response rate and reduction of threshold).  
Finally, the interaction of GHR and COC (10.0 nMol/rat GHR and 2.5 mg/kg COC) 
caused a significant increase in threshold.  In other words, administration of GHR alone 
caused a decrease in reward-seeking behavior as measured through ICSS response, while 
COC alone caused an increase in reward-seeking behavior.  When GHR was 
administered together with COC it seemed to inhibit the effects of COC on ICSS; in 
other words, there was a significantly smaller increase in reward-seeking behavior than 
that normally produced by the administration of COC alone.  These findings suggest that 
GHR decreases reward-seeking behavior when administered alone but may also inhibit 
the effects of COC on reward-seeking behavior by affecting the reinforcement pathway 
in the brain. 
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These results support the hypotheses that GHR alone would inhibit ICSS responding, 
COC alone would augment ICSS responding, and that the combination of the two drugs 
would cause a smaller increase in ICSS responding than that produced by COC alone. 
 
Conclusions 
Previous experiments on the effects of GHR on reward-related behavior have found 
similar results to the present study.  Davis et al. (2007) reported that administration of 
GHR facilitated the effects of COC on conditioned place preference for low COC doses 
(0.312 and 0.625 mg/kg) but not for higher COC doses (1.25 mg/kg).  The COC doses 
used in the Davis et al. study were not sufficient to activate the VTA, and therefore to 
cause more DA in the NA; however, when paired with a relatively small dose of GHR 
(5.0 nMol/rat), Davis et al. reported a significant conditioned place-preference effect.  
On the other hand, the combination of 5.0 nMol/rat GHR with a slightly larger dose of 
COC (1.25 mg/kg) did not facilitate conditioned place-preference.  Therefore, we can 
assume that low doses of COC may not fully activate the reward system in the brain. 
 
Additionally, unpublished data on the effects of GHR and COC on ICSS measured using 
a progressive ratio method (fig. 10) showed identical results to those found in the present 
study (Wellman; personal communication, 2010).  In the progressive ratio method of 
ICSS, rats are required to exert increasingly greater effort to earn a burst of ICSS 
stimulation; the breakpoint is defined as the point at which the rat stops responding.  In 
this figure, data represent the percent change of breakpoint for post- relative to pre-test 
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conditions; thus, for example, 75% would indicate an increase in effort exerted to 
receive reinforcement whereas -75% would indicate a decrease in effort exerted.  The 
data compiled in the progressive ratio study showed a dose-dependent increase following 
COC administration, a reduction following GHR, and a smaller increase after the 






































































Fig. 10. Percent Change from Baseline (+SEM) for Progressive Ratio ICSS.  
Percent change was measured as the difference in breakpoint for pre- versus post-
test conditions.  Rats were treated with either vehicle (0.5 ml saline), GHR (5.0 
nMol/rat), COC (1.25 or 5.0 mg/kg), or a combination of GHR and COC (5.0 
nMol/rat GHR and 1.25 mg/kg COC or 5.0 nMol/rat GHR and 5.0 mg/kg COC).  
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GHR receptors and DA receptors are found in many common areas in the reward 
pathway in the brain such as the VTA and NA in the mesolimbic pathway (Olszewski et 
al., 2008; Naleid et al., 2005).  Additionally, GHR receptors have been located on brain 
DA neurons (Davis et al., 2007).  The connection between DA and GHR suggests that 
both may play a role separately, or may interact, to affect the reward pathway in the 
brain.  One of the clearest connections between GHR and DA exists in the mesolimbic 
system between the VTA and the NA (when the VTA is activated, it causes a greater 
release of DA in the NA).  One possible theory to explain the effects of GHR and COC 
on reward-seeking behavior suggests that administration of GHR partially activates the 
VTA in the brain.  Therefore administration of COC doses (which on their own are 
insufficient to activate the VTA), when combined with GHR, become sufficient to 
activate this area and to allow the release of more DA in the NA which thus facilitates 
conditioned place preference.  However, this does not fully explain the results of the 
present study or the progressive ratio ICSS study (e.g. why does administration of GHR 
alone cause a decrease in ICSS if it is partially activating the VTA).   
 
Another theory to explain these results involves the dopamine transporter (DAT) which 
is responsible for the internalization of the neurotransmitter DA.  High levels of DAT 
cause smaller levels of DA in the synapse, whereas low levels of DAT cause higher 
levels of DA in the synapse.  COC cannot increase reinforcement without the presence 
of DAT because COC acts by blocking DAT (which increases DA levels).  A larger 
amount of DAT in the brain means that there is more DAT for COC to block; and, 
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therefore, the COC will have a larger reinforcing effect.  In other words, larger amounts 
of DAT lead to greater effects of COC on reinforcement.  Unpublished data by Abizaid 
(2010) reports that mice with a GHR knockout gene (such mice retain the GHR receptor 
but lack plasma GHR) show an increase in DAT in the NA and lower levels of DA in the 
NA.  This data suggest that administration of GHR alone may cause a decrease of DAT 
in the NA, which in turn causes an increase in the levels of synaptic DA in the NA 
(longer-lasting DA in the synapse).  At present, we are unsure how this effect of GHR 
when administered alone causes a decreased in reward-seeking behavior in ICSS.  It is 
possible that other neural systems (e.g. interaction of the medial prefrontal cortex with 
the VTA and NA) are also affected by the administration of GHR and are responsible for 
portions or all of the observed effect. 
 
The interaction of GHR and COC is interesting because administration of GHR seemed 
to inhibit the reinforcing effects of COC.  It is possible that GHR inhibits the reinforcing 
effects of COC by inhibiting DAT in the mesolimbic pathway (causing down-regulation 
of DAT in the NA) which decreases the number of DAT available to be blocked by COC 
which in turn causes a smaller reinforcing effect of COC (and also increases synaptic 
DA levels).  Supporting this theory, Thomsen et al. (2009) reported that DAT knockout 
mice failed to show reliable COC-induced SA which suggests that DAT is critical in 
mediating the reinforcing effects of COC. 
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The manipulation that GHR demonstrates on the effects of COC on reinforcement 
indicates the possibility of its use in treatment of COC addicts.  A preliminary study in 
our lab suggests that GHR reduces operant responding for COC.  Therefore, similar to 
the use of naloxone or naltrexone to treat opioid addiction, the ability of GHR to inhibit 
the effects of COC could be utilized during COC addiction treatment by administration 
of a GHR agonist.   
 
Future research 
In future studies, we plan to examine the effects of a GHR antagonist on ICSS 
responding and other paradigms used to measure reward-seeking behavior.  
Additionally, we plan to examine the effects of GHR and COC administration in GHR 
receptor knockout rats in ICSS, SA, and locomotion studies.  Results consistent with 
those found in previous literature would bolster the claim that GHR could be used in 
treatment of psychostimulant addiction.  Additional future research could examine the 
differences between the effects of GHR administration on acute versus chronic 
psychostimulant administration (both acquisition of SA and sensitization to the drug). 
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